
Scientists at the University of Missouri have developed a patient specific, precision medicine treatment for bone cancer in dogs. The …

Regeneron Pharmaceuticals have announced that they will collaborate with the Massachusetts-based gene therapy specialist Bluebird bio in an effort to …

A targeted T-cell oncology therapy has successfully treated a second baby with aggressive leukaemia who has remained in remission after …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

